Partial splenic embolization combined with endoscopic therapies and NSBB decreases the variceal rebleeding rate in cirrhosis patients with hypersplenism: a multicenter randomized controlled trial

[1] Brunner F(2017)Prevention and treatment of variceal haemorrhage in 2017 Liver Int 37 104-115

[2] Berzigotti A(2014)Drugs plus ligation to prevent rebleeding in cirrhosis: an updated systematic review Liver Int 34 823-833

[3] Bosch J(2003)Prevention of variceal rebleeding Lancet (Lond Engl) 361 952-954

[4] Puente A(2015)Expanding consensus in portal hypertension: report of the Baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension J Hepatol 63 743-752

[5] Hernández-Gea V(2016)Long-term efficacy of endoscopic ligation plus cyanoacrylate injection with or without sclerotherapy for variceal bleeding J Dig Dis 17 252-259

[6] Graupera I(2017)The spleen in liver cirrhosis: revisiting an old enemy with novel targets J Transl Med 15 111-1205

[7] Roque M(2003)Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis Gut 52 1200-184

[8] Colomo A(2005)Partial splenic embolization in patients with cirrhosis: efficacy, tolerance and long-term outcome in 32 patients Eur J Gastroenterol Hepatol 17 179-314

[9] Poca M(1993)Partial splenic embolization for the treatment of hypersplenism in cirrhosis Hepatology 18 309-622

[10] Bosch J(2007)Evaluation of the effect of partial splenic embolization on platelet values for liver cirrhosis patients with thrombocytopenia World J Gastroenterol 13 619-954

[1] Brunner F(2017)Prevention and treatment of variceal haemorrhage in 2017 Liver Int 37 104-115

[2] Berzigotti A(2014)Drugs plus ligation to prevent rebleeding in cirrhosis: an updated systematic review Liver Int 34 823-833

[3] Bosch J(2003)Prevention of variceal rebleeding Lancet (Lond Engl) 361 952-954

[4] Puente A(2015)Expanding consensus in portal hypertension: report of the Baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension J Hepatol 63 743-752

[5] Hernández-Gea V(2016)Long-term efficacy of endoscopic ligation plus cyanoacrylate injection with or without sclerotherapy for variceal bleeding J Dig Dis 17 252-259

[6] Graupera I(2017)The spleen in liver cirrhosis: revisiting an old enemy with novel targets J Transl Med 15 111-1205

[7] Roque M(2003)Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis Gut 52 1200-184

[8] Colomo A(2005)Partial splenic embolization in patients with cirrhosis: efficacy, tolerance and long-term outcome in 32 patients Eur J Gastroenterol Hepatol 17 179-314

[9] Poca M(1993)Partial splenic embolization for the treatment of hypersplenism in cirrhosis Hepatology 18 309-622

[10] Bosch J(2007)Evaluation of the effect of partial splenic embolization on platelet values for liver cirrhosis patients with thrombocytopenia World J Gastroenterol 13 619-954